ESR1 and neoplasm: pH-sensitive liposomes incorporating estrone derivative conjugated to DSPE-PEG (ES-PEG-DSPE), were developed by Paliwal et al. (106) to targetly deliver DXR to estrogen receptors (ER)-bearing tumor cells.